T. Brodowicz
Impact in
-
- Sarcoma Diagnosis and Treatment
- Oral health in cancer treatment
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- Cancer Treatment and Pharmacology
Papers in
-
- Sarcoma Diagnosis and Treatment 9
- Advanced Breast Cancer Therapies 5
- Oncology 14
- Cancer Treatment and Pharmacology 7
- Vascular Tumors and Angiosarcomas 4
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 1
- Co-authors
- C Wiltschke (5 shared papers)Kenneth John O'Byrne (1 shared paper)Michael Hejna (6 shared papers)Ch. Manegold (1 shared paper)C C Zielinski (2 shared papers)Gabriele Amann (7 shared papers)Wolfgang J. Köstler (3 shared papers)Werner Scheithauer (4 shared papers)
In The Last Decade
T. Brodowicz
24 papers receiving 595 citations
Peers
Comparison fields: 5 of 56
- Pulmonary and Respiratory Medicine 323
- Oncology 249
- Gastroenterology 18
- Cardiology and Cardiovascular Medicine 67
- Otorhinolaryngology 12
Countries citing papers authored by T. Brodowicz
This map shows the geographic impact of T. Brodowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Brodowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Brodowicz more than expected).
Fields of papers citing papers by T. Brodowicz
This network shows the impact of papers produced by T. Brodowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Brodowicz. The network helps show where T. Brodowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Brodowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 91 | |
| 2 | 2018 | 86 | |
| 3 | 2001 | 53 | |
| 4 | 2012 | 52 | |
| 5 | 2001 | 48 | |
| 6 | 1997 | 41 | |
| 7 | 1998 | 41 | |
| 8 | 1998 | 37 | |
| 9 | 2003 | 33 | |
| 10 | 2018 | 31 | |
| 11 | 2014 | 29 | |
| 12 | Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract. | 2001 | 20 |
| 13 | 1998 | 20 | |
| 14 | 1998 | 12 | |
| 15 | 2001 | 6 | |
| 16 | 2014 | 4 | |
| 17 | 1998 | 3 | |
| 18 | 2000 | 2 | |
| 19 | 2010 | 2 | |
| 20 | 2001 | 2 |
About T. Brodowicz
T. Brodowicz is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Hematology and Neurology, having authored 25 papers that have together received 619 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (5 papers), Vascular Tumors and Angiosarcomas (4 papers), HER2/EGFR in Cancer Research (3 papers), Cardiac tumors and thrombi (2 papers), Breast Cancer Treatment Studies (2 papers) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (323 citations), Oncology (249 citations), Gastroenterology (18 citations), Cardiology and Cardiovascular Medicine (67 citations) and Otorhinolaryngology (12 citations). T. Brodowicz has collaborated with scholars based in Austria, Germany and Italy. Frequent co-authors include C Wiltschke, Kenneth John O'Byrne, Michael Hejna, Ch. Manegold, C C Zielinski, Gabriele Amann, Wolfgang J. Köstler, Werner Scheithauer, Reinhard Windhager and Markus Raderer. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, British Journal of Cancer, Oncology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.